3alexd/E+ via Getty Images Asensus Surgical ( NYSE: ASXC ) is now a part of Karl Storz under an acquisition of the former for $0.35 a share that has now closed. Asensus had warned earlier this month it might file for bankruptcy if shareholders didn't approve the deal.
The company is known for its Senhance surgical system. Its next-generation LUNA surgical system is under development. More on Asensus Surgical Asensus Surgical, Inc.
(ASXC) Q2 2024 Earnings Call Transcript Asensus says it expects to file for bankruptcy if merger vote fails Seeking Alpha’s Quant Rating on Asensus Surgical Historical earnings data for Asensus Surgical.
